Literature DB >> 29895010

Metabolic Syndrome in Thyroid Disease.

K Alexander Iwen, Rebecca Oelkrug, Hannes Kalscheuer, Georg Brabant.   

Abstract

Cardiometabolic risk factors like abdominal obesity, hyperglycemia, low high-density lipoprotein (HDL) cholesterol, elevated triglycerides, and hypertension are defined as metabolic syndrome (MetS), which represents one of the most frequent endocrine disorders particularly in a society with increasing weight problems. As more and more evidence is accumulated that thyroid hormones affect components of the MetS, the present review aims to summarize the rapidly expanding knowledge on the pathophysiological interaction between thyroid hormone status and MetS. The review is based on a PubMed search for combinations of thyroid hormone action and MetS, blood pressure, hypertension, hyperlipidemia, cholesterol, HDL cholesterol, glucose, diabetes mellitus, body weight, or visceral fat. A special focus was given for manuscripts published after 2000 but we included seminal papers published before year 2000 as well.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2018        PMID: 29895010     DOI: 10.1159/000485996

Source DB:  PubMed          Journal:  Front Horm Res        ISSN: 0301-3073            Impact factor:   2.606


  5 in total

1.  Thyroid hormone levels are associated with metabolic components: a cross-sectional study.

Authors:  Ante Punda; Veselin Škrabić; Vesela Torlak; Ivana Gunjača; Vesna Boraska Perica; Ivana Kolčić; Ozren Polašek; Caroline Hayward; Tatijana Zemunik; Antonela Matana
Journal:  Croat Med J       Date:  2020-07-05       Impact factor: 1.351

Review 2.  Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Ecaterina Neculae; Claudia Florida Costea; Manuela Ciocoiu; Loredana Liliana Hurjui; Claudia Cristina Tarniceriu; Mariana Floria
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

3.  Lower normal free thyroxine is associated with a higher risk of metabolic syndrome: a retrospective cohort on Chinese population.

Authors:  Xi Ding; Chun-Ying Zhu; Rui Li; Li-Ping Wu; Yue Wang; Shi-Qian Hu; Yi-Ming Liu; Feng-Yi Zhao; Yang Zhao; Meng Zhang; Ming-Qian He; Zi-Yi Chen; Bing-Yin Shi
Journal:  BMC Endocr Disord       Date:  2021-03-04       Impact factor: 2.763

4.  Adjusted association between type 2 immunity and low risk thyroid nodules: a retrospective cohort study.

Authors:  Sanxing Wang; Xia Wang; Xiang Hua; Shichao Jiang; Yong Xie; Hongying Liu
Journal:  BMC Endocr Disord       Date:  2022-01-04       Impact factor: 2.763

5.  Association between thyroid hormone and components of metabolic syndrome in euthyroid Korean adults: A population-based study.

Authors:  Kyung A Shin; Eun Jae Kim
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.